Literature DB >> 16039752

Endogenous opiates and behavior: 2004.

Richard J Bodnar1, Gad E Klein.   

Abstract

This paper is the 27th consecutive installment of the annual review of research concerning the endogenous opioid system, now spanning over 30 years of research. It summarizes papers published during 2004 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior, and the roles of these opioid peptides and receptors in pain and analgesia; stress and social status; tolerance and dependence; learning and memory; eating and drinking; alcohol and drugs of abuse; sexual activity and hormones, pregnancy, development and endocrinology; mental illness and mood; seizures and neurologic disorders; electrical-related activity and neurophysiology; general activity and locomotion; gastrointestinal, renal and hepatic functions; cardiovascular responses; respiration and thermoregulation; and immunological responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039752     DOI: 10.1016/j.peptides.2005.06.010

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  16 in total

1.  Exploring the Backbone of Enkephalins To Adjust Their Pharmacological Profile for the δ-Opioid Receptor.

Authors:  Arnaud Proteau-Gagné; Véronique Bournival; Kristina Rochon; Yves L Dory; Louis Gendron
Journal:  ACS Chem Neurosci       Date:  2010-09-17       Impact factor: 4.418

Review 2.  Protease pathways in peptide neurotransmission and neurodegenerative diseases.

Authors:  Vivian Y H Hook
Journal:  Cell Mol Neurobiol       Date:  2006-05-25       Impact factor: 5.046

Review 3.  Response of substances co-expressed in hypothalamic magnocellular neurons to osmotic challenges in normal and Brattleboro rats.

Authors:  Jana Bundzikova; Zdeno Pirnik; Dora Zelena; Jens D Mikkelsen; Alexander Kiss
Journal:  Cell Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.046

4.  Mu and kappa opioid receptors of the periaqueductal gray stimulate and inhibit thermogenesis, respectively, during psychological stress in rats.

Authors:  Caroline Cristina-Silva; Victor Martins; Luciane H Gargaglioni; Kênia C Bícego
Journal:  Pflugers Arch       Date:  2017-04-04       Impact factor: 3.657

5.  Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia.

Authors:  L Gendron; J E Pintar; C Chavkin
Journal:  Neuroscience       Date:  2007-10-05       Impact factor: 3.590

Review 6.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

7.  Long-term behavioral effects in a rat model of prolonged postnatal morphine exposure.

Authors:  Michael M Craig; Dusica Bajic
Journal:  Behav Neurosci       Date:  2015-07-27       Impact factor: 1.912

8.  Distinct effects of individual opioids on the morphology of spines depend upon the internalization of mu opioid receptors.

Authors:  Dezhi Liao; Olga O Grigoriants; Wei Wang; Katie Wiens; Horace H Loh; Ping-Yee Law
Journal:  Mol Cell Neurosci       Date:  2007-05-04       Impact factor: 4.314

9.  Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease.

Authors:  William J Meilandt; Gui-Qiu Yu; Jeannie Chin; Erik D Roberson; Jorge J Palop; Tiffany Wu; Kimberly Scearce-Levie; Lennart Mucke
Journal:  J Neurosci       Date:  2008-05-07       Impact factor: 6.167

Review 10.  Dynorphin and the pathophysiology of drug addiction.

Authors:  T S Shippenberg; A Zapata; V I Chefer
Journal:  Pharmacol Ther       Date:  2007-07-24       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.